Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type Sort ascending
Focus Area
Country
Application Due Date
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Cancer Registry
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Oncology Congo, The Democratic Republic
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Oncology Japan
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Spain
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Title
Grant Type Sort ascending
Focus Area
Country
Application Due Date
Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)
Release Date:
Review Process: Pfizer Internal
Research Hospital All
Pfizer Innovation Challenge: Patient Preference Database Blueprint
Release Date:
Review Process: Expert Review Panel
Research Support for the Professions All
PCF-Pfizer-Myovant Relugolix Challenge Awards
Release Date:
Partner: The Prostate Cancer Foundation and Myovant Sciences GmbH
Review Process: Expert Review Panel
Research Oncology USA
A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color
Release Date:
Partner: Conquer Cancer, The ASCO Foundation
Review Process: Expert Review Panel
Research Oncology USA
COVID-19 Epidemiology Research
Release Date:
Review Process: Pfizer Internal
Research Vaccines Algeria, Egypt, Indonesia, Lebanon, Philippines, Thailand, Tunisia, Vietnam
Data generation on the treatment of Metastatic Breast Cancer with CDK 4/6 inhibitors
Release Date:
Review Process: Expert Review Panel
Research Oncology Portugal
Burden of Community Acquired Pneumonia
Release Date:
Review Process: Pfizer Internal
Research Vaccines USA
Development of Talazoparib for Prostate Cancer
Release Date:
Partner: National Comprehensive Cancer Network
Review Process: Expert Review Panel
Research Oncology USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Enzalutamide in the Treatment of Prostate Cancer
Release Date:
Partner: National Comprehensive Cancer Network, Astellas
Review Process: Expert Review Panel
Research Oncology USA
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom
2021 Growth Hormone Research (All countries except for the United States)
Release Date:
Review Process: Pfizer Internal
Research Rare Disease All